Evidence map›Paper›PMID 34163963›Full record

ReviewChemical science2020

Phosphorus-ylides: powerful substituents for the stabilization of reactive main group compounds.

Abir Sarbajna, V S V S N Swamy, Viktoria H Gessner

Abstract readReview
In one paragraph

Review in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Nucleophilic Addition of Stabilized Phosphorus Ylides toMolecules (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Accessing Cationic α-Silylated and α-Germylated Phosphorus Ylides.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abir SarbajnaFaculty of Chemistry and Biochemistry, Chair of Inorganic Chemistry II, Ruhr University Bochum Universitätsstr. 150 44801 Bochum Germany viktoria.gessner@rub.de.ORCID https://orcid.org/0000-0003-2478-5044
V S V S N SwamyFaculty of Chemistry and Biochemistry, Chair of Inorganic Chemistry II, Ruhr University Bochum Universitätsstr. 150 44801 Bochum Germany viktoria.gessner@rub.de.
Viktoria H GessnerFaculty of Chemistry and Biochemistry, Chair of Inorganic Chemistry II, Ruhr University Bochum Universitätsstr. 150 44801 Bochum Germany viktoria.gessner@rub.de.ORCID https://orcid.org/0000-0001-6557-2366

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphorus ylides are 1,2-dipolar compounds with a negative charge on the carbon atom. This charge is stabilized by the neighbouring onium moiety, but can also be shifted towards other substituents thus making ylides strong π donor ligands and hence ideal substituents to stabilize reactive compounds such as cations and low-valent main group species. Furthermore, the donor strength and the steric properties can easily be tuned to meet different requirements for stabilizing reactive compounds and for tailoring the properties and reactivities of the main group element. Although the use of ylide substituents in main group chemistry is still in its infancy, the first examples of isolated compounds impressively demonstrate the potential of these ligands. This review summarizes the most important discoveries also in comparison to other substituents, thus outlining avenues for future research directions.

Identifiers

PMID34163963
PMCPMC8179322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.